Standard Biotools (LAB) Price to Earnings (2011 - 2026)

Standard Biotools (LAB) has reported Price to Earnings for 16 consecutive years, with 12.01 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Earnings rose 12.25% year-over-year to 12.01 in Q2 2026; TTM through Jun 2026 was 3.79, a 199.64% increase from a year earlier, with the FY2025 full-year figure at 6.6, down 84.8% from the prior year.
• Price to Earnings was 12.01 for Q2 2026 at Standard Biotools, down from 2.82 in the prior quarter.
• Over five years, Price to Earnings peaked at 25.65 in Q4 2025 and troughed at 47.4 in Q4 2023.
• A 5-year average of 11.22 and a median of 11.48 in 2023 frame the typical range for Price to Earnings.
• Across the five-year window, Price to Earnings sank 962.43% in 2023 and jumped 232.27% in 2025, its largest moves.
• Over 5 years, Price to Earnings stood at 4.46 in 2022, then slumped by 962.43% to 47.4 in 2023, then jumped by 59.09% to 19.39 in 2024, then jumped by 232.27% to 25.65 in 2025, then plunged by 146.83% to 12.01 in 2026.
• The last three Price to Earnings figures came in at 12.01 (Q2 2026), 2.82 (Q1 2026), and 25.65 (Q4 2025), per Business Quant data.